p53–Penetratin Chimeric Peptide (PNC-27)

PNC-27 Compound Overview

PNC-27 is a p53–penetratin chimeric peptide identified by the PNC-27 designation. This page identifies the material as PNC-27. The PNC-27 identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.

Chimeric Peptide Research Context

The research record for PNC-27 is organized around p53-related peptide research, chimeric peptide characterization, protein-interaction studies, and analytical peptide workflows. For PNC-27, those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome.

Available PNC-27 Specifications

The live selector currently lists 5mg for PNC-27, supplied as 10 Vials. Each selectable PNC-27 specification retains its own SKU, displayed price, inventory record, and matched image, so the chosen option can be checked without relying on a generic dose range.

PNC-27 Identity & Composition

Record boundary: Molecular identifiers describe the named PNC-27 form; lot-specific analytical results remain in the matched COA record.

How to Read the PNC-27 COA

Use the Certificate of Analysis panel to review documentation available for PNC-27. When examining a record, confirm the product name, selected specification, batch number, test date, reported purity, net content, and the tests included. The PNC-27 identity table and batch documentation serve different purposes, so catalogue identifiers should be evaluated separately from lot-specific analytical results.

Research Use Notice

This material is supplied for controlled laboratory and research use only. It is not intended for human or animal consumption, diagnosis, treatment, administration, or therapeutic use. Buyers should review the selected specification and its matched documentation before ordering.